A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Gastric UlcerDuodenal Ulcer

Interventions

DRUG

TAK-438

Trial Locations (19)

Funabashi-shi

Noda

Fukuoka

Annaka-shi

Hiroshima

Hakodate-shi

Kitahiroshima-shi

Sapporo

Yubari-gun

Kanazawa

Sanuki-shi

Sendai

Nagasaki

Sasebo-shi

Fuchu-shi

Katsushika-ku

Meguro-ku

Minato-ku

Nakano-ku